Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

28 Day Repeat Dose in Cystic Fibrosis Patients

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: May 14, 2009
Last updated: May 31, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 15, 2012